In its role as facilitator of an innovation ecosystem, the TLS Foundation becomes more and more an aggregator within the life sciences field, both locally and internationally.v Between the main activities we have the coordination, planning and implementation of policy interventions at supranational scale, through the participation to EU and international projects, such as CSAs (Coordination and Support Actions), RIAs (Research and Innovation Actions) and ERA-NETs (European Research Are Networks). In this sense, TLS is part of several CSAs to reinforce the international collaboration on strategic topics, particularly on Personalised Medicine. Through Research and Innovation projects, TLS enhances the competences of the UVaR Department supporting the regional research groups, and cooperates with the Tuscany Region to increase investments in excellent research on the territory (rare diseases, personalised medicine and oncology). TLS has also developed and intensified collaboration agreements and networking activities thanks to the many national and international partnerships that have been put in place during the years, thanks to a public-private model.
EUROPEAN AND INTERNATIONAL PROJECTS
Despite progress in high-risk maternity management, Cerebral Palsy (CP) is the most common cause of physical disability in infants in both high- and low-income countries.
The main goal of the BORNTOGEtTHERe Project is the implementation of early detection and early intervention service delivery in infants at risk for cerebral palsy to promote infants’ psychomotor development and maternal health, through the development of the first clinical practice guidelines in Europe, in low-income countries and among hard-to-reach populations.
MammoScreen ‘Innovative and safe microwave-based imaging technology to make breast cancer screening more accurate, inclusive and female-friendly’ is a four years European project, co-funded by the European Commission and United Kingdom, with a total budget of 7 million euros.
The health systems’ transformation from reactive treatment models to predictive and preventive systems, hence the implementation of the personalized medicine paradigm, requires cooperation and coordination among different stakeholders and European programs, such as Member States and, above all, regions, with the aim of building an integrated action plan to foster innovation in this field.
The health systems’ transformation from reactive treatment models to predictive and preventive systems, hence the implementation of the personalized medicine paradigm, requires cooperation and coordination among different stakeholders, not only at European and Community level, with the aim of building an integrated action plan to foster innovation in this field.
visit the other sections
The Fondazione Toscana Life Sciences is the operational entity that coordinates and manages the activities of the Tuscan Life Sciences Cluster.
ALISEI (Advanced Life Science in Italy) is the National Technology Cluster for Life Sciences, which aims to promote interaction between the research system, the entrepreneurial and productive fabric and public institutions in the healthcare sector, a strategic research and innovation nexus for Italy.
TLS works to foster dialogue and partnerships between public and private entities. It has created and continues to implement collaboration networks in the field of life sciences with the aim of offering incubated companies access to contacts and opportunities.